The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
Pancreatic ductal adenocarcinoma (PDAC) is still difficult to treat due to insufficient methods for early diagnosis and prediction of therapy response. Furthermore, surveillance after curatively intended surgery lacks adequate methods for timely detection of recurrence. Therefore, several molecules...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Revisão |
| 語言: | 英语 |
| 出版: |
2022
|
| 在線閱讀: | https://doi.org/10.3390/cancers14010217 https://www.mdpi.com/2072-6694/14/1/217/pdf?version=1641282367 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|